MTOR and cancer: Aberrant signaling of mTOR is involved in many pathological states, such as cancer, cardiovascular disease, inflammation, autoimmunity, and metabolic disorders (Dowling et al., 2010; Procaccini et al., 2010; Fasolo and Sessa, 2014; Chen et al., 2019).